| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79c2b174c7d922dba417d742d270b92c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5af8e5f4257e556548b2ae50c236d1ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a78330037b8264a637a8c2a130ad435c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be3928f66bb2545a8175c61c56146b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83b66d3d39cdfc21459a35ec82336e14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 |
| filingDate |
2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55e09b1e5b5dde82337dbe6eec8c1c46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cf70a97a3eb3ca44f4187adfb32ed77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6f0b22d4dd24fda822704a17bbb205f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f38c860d049a80910c5162705be99ec7 |
| publicationDate |
2005-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005079792-A1 |
| titleOfInvention |
Preventive or therapeutic agents for severe diabetic retinopathy |
| abstract |
Preventive or therapeutic agents for severe diabetic retinopathy containing as the active ingredient hydantoin derivatives represented by the general formula (I), which agents are useful mainly as inhibitors against the evolution into nonproliferative diabetic retinopathy and/or proliferative diabetic retinopathy or inhibitors against the progression of nonproliferative diabetic retinopathy and/or proliferative diabetic retinopathy: (I) wherein X is halogeno or hydrogen; and R1 and R2 may be the same or different and are each hydrogen or optionally substituted C1-6 alkyl, or R1, R2 and the nitrogen atom optionally together with an additional nitrogen or oxygen atom may form a 5- or 6-membered heterocycle. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8536212-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011087066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008093691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2110141-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5363123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007069727-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012105610-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011136161-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2594267-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2110141-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103222974-A |
| priorityDate |
2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |